SCHEMBL30810265

SCHEMBL30810265

CN1CCN(CCOCc2cccc(C(F)(F)F)c2)CC1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CARM1 Q86X55 2/20 0.52
▸ PRMT6 Q96LA8 2/20 0.52
▸ LMNA P02545 3/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ IDO1 P14902 2/20 0.49
▸ GAA P10253 3/20 0.48
▸ KDM4E B2RXH2 3/20 0.48
▸ ALDH1A1 P00352 3/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ HTT P42858 1/20 0.48
▸ GALR3 O60755 1/20 0.47
▸ TACR1 P25103 3/20 0.47
▸ SIGMAR1 Q99720 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ CXCR1 P25024 1/20 0.47
▸ SLC6A4 P31645 1/20 0.46
▸ KIT P10721 1/20 0.45
▸ FLT3 P36888 1/20 0.45
▸ LTA4H P09960 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7289371 0.84 SMN1; SMN2 (0.52) CARM1PRMT6LMNASMN1; SMN2IDO1
SCHEMBL5695484 0.82 SIGMAR1 (0.63) LMNASMN1; SMN2GAAKDM4EALDH1A1
SCHEMBL30810302 0.80 KDM4E (0.72) LMNAGAAKDM4EALDH1A1KMT2A
SCHEMBL6928385 0.80 KDM4E (0.72) LMNAGAAKDM4EALDH1A1KMT2A
SCHEMBL27708411 0.76 IDO1 (0.72) IDO1GAAKDM4EALDH1A1TACR1
SCHEMBL30810184 0.76 IDO1 (0.58) IDO1HTTTACR1
SCHEMBL7134912 0.74 LTA4H (0.72) LMNASMN1; SMN2GAAKDM4EALDH1A1
SCHEMBL13736041 0.74 IDO1 (0.60) IDO1KMT2ATACR1MEN1
SCHEMBL30810275 0.74 IDO1 (0.60) IDO1KMT2ATACR1MEN1
SCHEMBL13677237 0.74 IDO1 (0.64) LMNAIDO1HTTTACR1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4583870-A2 MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER Mito Biopharma, LLC (US) 2025-07-16 — — EP disclosed
WO-2024054766-A2 MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER MITO BIOPHARMA, LLC (US) 2024-03-14 — — WO disclosed
Send feedback